ClinicalTrials.Veeva

Menu
I

Intrepid Research | Cincinnati, OH

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TAK-861
JZP-258
Pitolisant
Lorundrostat
Mazindol
TAK-994
AD504
Lemborexant
Solriamfetol
High-Sodium Oxybate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 33 total trials

A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients with Idiopathic Hypersomnia

The primary objective of this study is to assess the long-term safety and effectiveness of pitolisant in patients with idiopathic hypersomnia (IH) wh...

Active, not recruiting
Idiopathic Hypersomnia
Excessive Daytime Sleepiness
Drug: Pitolisant

a Phase 2 trial to evaluate the blood pressure-lowering effect of lorundrostat (an aldosterone synthase inhibitor), administered on a background of a...

Enrolling
Hypertension
Drug: Placebo
Drug: lorundrostat Dose 2

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling
Narcolepsy Type 1
Drug: TAK-861

The primary purpose of this study is to evaluate the efficacy of single oral doses of E2086 compared to placebo in the treatment of excessive daytime...

Enrolling
Narcolepsy Type 1 (NT1)
Drug: Active Comparator Placebo
Drug: E2086 Placebo

This study will assess the safety and efficacy of JZP258 (XYWAV) on sleepiness, polysomnography, and functional outcomes in patients with idiopathic...

Enrolling
Idiopathic Hypersomnia
Narcolepsy
Drug: JZP258 (XYWAV)

Researchers are looking for a better way to treat women who have sleep disturbances associated with menopause.Menopause is part of a natural aging pr...

Active, not recruiting
Sleep Disturbances Associated With Menopause
Other: Placebo
Drug: Elinzanetant

The aim of this study is to quantify the change in blood pressure when participants with narcolepsy treated with high-sodium oxybate are transitioned...

Enrolling
Narcolepsy
Drug: JZP258

This study intends to examine the utility of a home-use EEG-based sleep monitor for the diagnosis and evaluation of disorders of excessive sleepiness...

Enrolling
Sleep Disorder
Narcolepsy Type 1
Device: Dreem 3S recording

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Enrolling
Hypertension
Drug: lorundrostat
Drug: Placebo

The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive...

Enrolling
Obstructive Sleep Apnea
Drug: Acetazolamide
Drug: IHL-42X Low Dose

Trial sponsors

Takeda logo
Jazz Pharmaceuticals logo
Apnimed logo
Eisai logo
H
M
N
Axsome Therapeutics logo
B
Bayer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems